EMA and ECDC Collaborate on Vaccine Real-World Evidence Generation Efforts
December 13, 2022
Officials from the European Centre for Disease Prevention and Control (ECDC) and European Medicines Agency met earlier this month to begin a new collaboration intended to boost real-world evidence (RWE) generation for vaccine safety and efficacy trials. The collaboration, the Vaccine Monitoring Platform (VMP), will work to develop an RWE infrastructure for vaccines in the EU without outside industry funding.
According to Jane Byrne, “Through the VMP, the two agencies will coordinate and oversee such EU-Funded, independent, post-authorisation research. Emer Cooke, EMA’s executive director, said the additional evidence generated this way would enable it to continuously monitor the safety and effectiveness of vaccines.”
To read more, click here.
(Source: BioPharma Reporter, December 13th, 2022)
